This is a Validated Antibody Database (VAD) review about rat TEF 1, based on 11 published articles (read how Labome selects the articles), using TEF 1 antibody in all methods. It is aimed to help Labome visitors find the most suited TEF 1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
TEF 1 synonym: TEF-1

Knockout validation
Abcam
domestic rabbit monoclonal (EPR3967(2))
  • immunohistochemistry knockout validation; mouse; 1:100; loading ...; fig 1d
  • western blot knockout validation; mouse; 1:2000; loading ...; fig 6a, s3a
Abcam TEF 1 antibody (Abcam, ab133533) was used in immunohistochemistry knockout validation on mouse samples at 1:100 (fig 1d) and in western blot knockout validation on mouse samples at 1:2000 (fig 6a, s3a). PLoS ONE (2019) ncbi
Abcam
domestic rabbit monoclonal (EPR3967(2))
  • western blot; human; loading ...; fig 2a
Abcam TEF 1 antibody (Abcam, AB133533) was used in western blot on human samples (fig 2a). elife (2021) ncbi
domestic rabbit monoclonal (EPR3967(2))
  • chromatin immunoprecipitation; human; 1:20; loading ...; fig 6f
Abcam TEF 1 antibody (Abcam, ab133533) was used in chromatin immunoprecipitation on human samples at 1:20 (fig 6f). Int J Biol Sci (2021) ncbi
domestic rabbit monoclonal (EPR3967(2))
  • western blot; human; loading ...; fig 6e
Abcam TEF 1 antibody (Abcam, ab133533) was used in western blot on human samples (fig 6e). EBioMedicine (2020) ncbi
domestic rabbit monoclonal (EPR3967(2))
  • immunohistochemistry knockout validation; mouse; 1:100; loading ...; fig 1d
  • western blot knockout validation; mouse; 1:2000; loading ...; fig 6a, s3a
Abcam TEF 1 antibody (Abcam, ab133533) was used in immunohistochemistry knockout validation on mouse samples at 1:100 (fig 1d) and in western blot knockout validation on mouse samples at 1:2000 (fig 6a, s3a). PLoS ONE (2019) ncbi
domestic rabbit monoclonal (EPR3968(2))
  • western blot; human; 1:1000; loading ...; fig 2b
Abcam TEF 1 antibody (Abcam, ab133535) was used in western blot on human samples at 1:1000 (fig 2b). Biochem J (2018) ncbi
domestic rabbit monoclonal (EPR3967(2))
  • western blot; human
In order to investigate Tead4-mediated transcriptional networks in various types of cancer cells, Abcam TEF 1 antibody (Abcam, ab133533) was used in western blot on human samples . Cell Rep (2016) ncbi
Santa Cruz Biotechnology
mouse monoclonal
  • western blot; mouse; 1:200; fig 2g
Santa Cruz Biotechnology TEF 1 antibody (Santa Cruz, sc393976) was used in western blot on mouse samples at 1:200 (fig 2g). Cell Death Discov (2021) ncbi
mouse monoclonal (H-4)
  • western blot; human; loading ...; fig 2a
Santa Cruz Biotechnology TEF 1 antibody (Santa Cruz Biotechnology, sc-376113) was used in western blot on human samples (fig 2a). Oncogene (2017) ncbi
mouse monoclonal (H-4)
  • chromatin immunoprecipitation; human; 1:100
Santa Cruz Biotechnology TEF 1 antibody (Santa Cruz, sc-376113 X) was used in chromatin immunoprecipitation on human samples at 1:100. Oncogene (2016) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D9X2L)
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig 8G
  • chromatin immunoprecipitation; mouse; loading ...; fig 8D
  • immunoprecipitation; mouse; 1:100; loading ...; fig 8C1
  • western blot; mouse; 1:1000; loading ...; fig 8F
Cell Signaling Technology TEF 1 antibody (Cell signaling, 12292) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 8G), in chromatin immunoprecipitation on mouse samples (fig 8D), in immunoprecipitation on mouse samples at 1:100 (fig 8C1) and in western blot on mouse samples at 1:1000 (fig 8F). elife (2017) ncbi
domestic rabbit monoclonal (D9X2L)
  • western blot; human; fig 1
Cell Signaling Technology TEF 1 antibody (Cell signaling, 12292) was used in western blot on human samples (fig 1). J Biol Chem (2016) ncbi
Articles Reviewed
  1. Qian B, Wang P, Zhang D, Wu L. m6A modification promotes miR-133a repression during cardiac development and hypertrophy via IGF2BP2. Cell Death Discov. 2021;7:157 pubmed publisher
  2. Merritt N, Garcia K, Rajendran D, Lin Z, Zhang X, Mitchell K, et al. TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex. elife. 2021;10: pubmed publisher
  3. Zheng T, Liu X, Li X, Wang Q, Zhao Y, Li X, et al. Dickkopf-1 promotes Vascular Smooth Muscle Cell proliferation and migration through upregulating UHRF1 during Cyclic Stretch application. Int J Biol Sci. 2021;17:1234-1249 pubmed publisher
  4. Yin L, Li W, Xu A, Shi H, Wang K, Yang H, et al. SH3BGRL2 inhibits growth and metastasis in clear cell renal cell carcinoma via activating hippo/TEAD1-Twist1 pathway. EBioMedicine. 2020;51:102596 pubmed publisher
  5. Liu R, Jagannathan R, Li F, Lee J, Balasubramanyam N, Kim B, et al. Tead1 is required for perinatal cardiomyocyte proliferation. PLoS ONE. 2019;14:e0212017 pubmed publisher
  6. Unterer B, Wiesmann V, Gunasekaran M, Sticht H, Tenkerian C, Behrens J, et al. IFN-γ-response mediator GBP-1 represses human cell proliferation by inhibiting the Hippo signaling transcription factor TEAD. Biochem J. 2018;475:2955-2967 pubmed publisher
  7. Zhou Y, Huang T, Zhang J, Wong C, Zhang B, Dong Y, et al. TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis. Oncogene. 2017;36:6518-6530 pubmed publisher
  8. Grove M, Kim H, Santerre M, Krupka A, Han S, Zhai J, et al. YAP/TAZ initiate and maintain Schwann cell myelination. elife. 2017;6: pubmed publisher
  9. Chen X, Stauffer S, Chen Y, Dong J. Ajuba Phosphorylation by CDK1 Promotes Cell Proliferation and Tumorigenesis. J Biol Chem. 2016;291:14761-72 pubmed publisher
  10. Liu X, Li H, Rajurkar M, Li Q, Cotton J, Ou J, et al. Tead and AP1 Coordinate Transcription and Motility. Cell Rep. 2016;14:1169-1180 pubmed publisher
  11. Qiao Y, Lin S, Chen Y, Voon D, Zhu F, Chuang L, et al. RUNX3 is a novel negative regulator of oncogenic TEAD-YAP complex in gastric cancer. Oncogene. 2016;35:2664-74 pubmed publisher